We are live on ! Find out more
CHRS icon

Coherus Oncology

122 hedge funds and large institutions have $842M invested in Coherus Oncology in 2016 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 37 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

68.52% more ownership

Funds ownership: 0%68.52% (+69%)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

19% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 37

14% more capital invested

Capital invested by funds: $741M → $842M (+$101M)

4% more funds holding

Funds holding: 117122 (+5)

92% less call options, than puts

Call options by funds: $268K | Put options by funds: $3.3M

Holders
122
Holders Change
+5
Holders Change %
+4.27%
% of All Funds
3.05%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
25
Increased
44
Reduced
37
Closed
19
Calls
$268K
Puts
$3.3M
Net Calls
-$3.03M
Net Calls Change
+$313K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$1.71M -$44.8K -1,600 -3%
First Trust Advisors
52
First Trust Advisors
Illinois
$1.69M +$1.68M +60,063 New
AC
53
Ascend Capital
California
$1.69M +$1.68M +60,000 New
Citigroup
54
Citigroup
New York
$1.62M +$979K +34,971 +155%
Thrivent Financial for Lutherans
55
Thrivent Financial for Lutherans
Minnesota
$1.61M +$1.6M +57,140 New
CEP
56
Chicago Equity Partners
Illinois
$1.6M +$1.59M +56,710 New
TC
57
TFS Capital
Pennsylvania
$1.48M +$1.22M +43,480 +481%
PAM
58
Panagora Asset Management
Massachusetts
$1.47M +$1.46M +52,138 New
BA
59
BlackRock Advisors
Delaware
$1.32M -$863K -30,845 -40%
CCMH
60
Cornerstone Capital Management Holdings
New York
$1.28M +$1.27M +45,400 New
Handelsbanken Fonder
61
Handelsbanken Fonder
Sweden
$1.27M
Macquarie Group
62
Macquarie Group
Australia
$1.2M -$439K -15,700 -27%
Goldman Sachs
63
Goldman Sachs
New York
$1.17M +$324K +11,590 +39%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.05M
Russell Investments Group
65
Russell Investments Group
United Kingdom
$1.05M +$1.04M +37,117 New
Marshall Wace
66
Marshall Wace
United Kingdom
$1.02M +$1.02M +36,303 New
TD Asset Management
67
TD Asset Management
Ontario, Canada
$978K +$53.2K +1,900 +6%
NFA
68
Nationwide Fund Advisors
Ohio
$945K -$91.5K -3,270 -9%
ProShare Advisors
69
ProShare Advisors
Maryland
$945K +$76K +2,715 +9%
ARTA
70
A.R.T. Advisors
New York
$940K +$697K +24,900 +293%
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$939K +$88.7K +3,170 +10%
GAM
72
Gotham Asset Management
New York
$928K +$437K +15,619 +90%
AllianceBernstein
73
AllianceBernstein
Tennessee
$927K
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$907K +$68.1K +2,433 +8%
SM
75
Sabby Management
Florida
$806K +$801K +28,618 New

CHRS Hedge Fund Activity: Q4 2016 in Review

122 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2016, worth a combined $842M — up 14% from $741M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new CHRS positions and 19 closed out — a net gain of 6 holders — while 44 added to existing stakes and 37 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $16.8M. The largest seller was Millennium Management, cutting an estimated $13.4M.

  • 122 institutional investors held Coherus Oncology (CHRS) as of Q4 2016, up from 117 in Q3 2016.
  • Funds reported $842M of Coherus Oncology stock for Q4 2016, up 14% quarter-over-quarter.
  • 25 funds opened new Coherus Oncology positions in Q4 2016 and 19 closed out, a net change of +6 holders.
  • The largest Coherus Oncology buyer in Q4 2016 was Point72 Asset Management, an estimated $16.8M added.
  • The largest Coherus Oncology seller in Q4 2016 was Millennium Management, an estimated $13.4M sold.

Based on aggregated 13F filings for Q4 2016.